Brevan Howard Capital Management LP Ventyx Biosciences, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q2 2025
A detailed history of Brevan Howard Capital Management LP transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 114,831 shares of VTYX stock, worth $405,353. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114,831Holding current value
$405,353% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VTYX
# of Institutions
122Shares Held
49.4MCall Options Held
70.4KPut Options Held
51.4K-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.9MShares$20.8 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$16.8 Million0.0% of portfolio
-
Affinity Asset Advisors, LLC New York, NY4.54MShares$16 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$11.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$10.9 Million0.4% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $200M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...